MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Antiphospholipid syndrome presenting with craniocervical dystonia: A case study

    C. Dietiker, C. Clelland, S. Gupta, M. Richie, M. Shah, I. Bledsoe (San Francisco, CA, USA)

    Objective: Antiphospholipid Syndrome (APLS) is a hypercoagulable state characterized by arterial or venous thrombosis and/or pregnancy morbidity with laboratory evidence of antiphospholipid antibodies. Movement disorders…
  • 2017 International Congress

    Efficacy of IncobotulinumtoxinA for the Treatment Of Shoulder Spasticity

    D. Simpson, J. Wissel, D. Bensmail, A. Scheschonka, B. Flatau-Baqué, O. Simon (New York, NY, USA)

    Objective: To evaluate efficacy of botulinum toxin for shoulder spasticity using a post-hoc analysis. Background: Botulinum toxin has been shown to be effective for treating…
  • 2017 International Congress

    Basal Ganglia Circuits for Motor and Behavioral, Emotional Performances

    F. Fujiyama (Kyotanabe, Japan)

    Objective: The present study aimed to identify which neurons in the basal ganglia (BG)  target dopaminergic or GABAergic neurons in SN pars compacta (SNc) or…
  • 2017 International Congress

    A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome

    D. Gilbert, T. Murphy, J. Jankovic, C. Budman, K. Black, R. Kurlan, K. Coffman, J. McCracken, J. Juncos, J. Grant, R. Chipkin (Cincinnati, OH, USA)

    Objective: To investigate the efficacy and safety of the selective dopamine D1 receptor antagonist ecopipam in children and adolescents with Tourette Syndrome (TS). Background: Dysregulation…
  • 2017 International Congress

    Clinical and demographics of cervical dystonia related to the direction of the neck movement

    K. Asanuma (Kyoto, Japan)

    Objective: The objectives of this report is to survey whether the type of torticollis (i.e. rotation, retrocolis and anterocolis) is related to the clinical characteristics…
  • 2017 International Congress

    Dystonia-like phenotype in a DYT1 rat model after peripheral trauma

    S. Knorr, K. Grundmann-Hauser, J. Volkmann, C.W. Ip (Wuerzburg, Germany)

    Objective: Establishment and characterization of a DYT1 rat model with dystonia-like movements after sciatic nerve crush injury. Background: Penetrance of DYT1 dystonia is markedly reduced…
  • 2017 International Congress

    The Volatility of Local Field Potential Oscillations in Dystonia and Parkinson’s disease

    D. Pina Fuentes, J. van Zijl, J.-W. Elting, G. Drost, M. van Egmond, M. Oterdoom, M. Tijssen, M. van Dijk, M. Beudel (Groningen, Netherlands)

    Objective: To assess the volatility of low frequency (4-12Hz) and beta-band (13-30Hz) oscillations in local field potentials (LFPs) in dystonia and compare this to LFPs…
  • 2017 International Congress

    Trisomy 8 Mosaicism and dystonia: a THAP1 overdose?

    A. Fois, M. Tchan, V. Fung (Westmead, Australia)

    Objective: We report a case of Trisomy 8 Mosaicism (T8M, Warkany Syndrome) with craniocervical and hand dystonia, an hitherto unreported disease association. Background: T8M is…
  • 2017 International Congress

    Cinnamomum verum on Learning and Memory in Wistar Albino Rats

    N. AHMED, D. AGRAWAL, A. CHUGHTAI (ALIGARH, India)

    Objective: Several studies have been performed on Cinnamomum verum,but not much is known about the activity of Cinnamomum verum on Memory Enhancing.Therefore Cinnamomum verum is selected…
  • 2017 International Congress

    CSF, plasma and saliva alpha-Synuclein in moderately advanced Parkinson’s disease cohort: the BioFIND study

    R. Alcalay, A. Amara, P. Taylor, H. Andrews, J. Goldman, T. Xi, P. Tuite, C. Henchcliffe, P. Hogarth, S. Frank, M.-H. Saint Hilaire, A. Naito, M. Frasier, V. Arnedo, A. Reimer, M. Sutherland, C. Swanson-Fischer, K. Gwinn, U. Kang (NYC, NY, USA)

    Objective: To test if alpha-synuclein (α-syn) levels in CSF, plasma and saliva predict PD status in the BioFind cohort, and to test whether α-syn levels…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley